Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Cash from Financing Activities (2016 - 2025)

Cross Country Healthcare (CCRN) has disclosed Cash from Financing Activities for 16 consecutive years, with -$6.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities fell 59.9% year-over-year to -$6.5 million, compared with a TTM value of -$13.0 million through Dec 2025, up 72.24%, and an annual FY2025 reading of -$13.0 million, up 72.24% over the prior year.
  • Cash from Financing Activities was -$6.5 million for Q4 2025 at Cross Country Healthcare, down from -$6000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $78.2 million in Q4 2021 and bottomed at -$114.9 million in Q2 2023.
  • Average Cash from Financing Activities over 5 years is -$12.5 million, with a median of -$6.5 million recorded in 2023.
  • The sharpest move saw Cash from Financing Activities surged 2867.07% in 2021, then crashed 756.56% in 2022.
  • Year by year, Cash from Financing Activities stood at $78.2 million in 2021, then crashed by 92.23% to $6.1 million in 2022, then tumbled by 205.61% to -$6.4 million in 2023, then soared by 36.46% to -$4.1 million in 2024, then plummeted by 59.9% to -$6.5 million in 2025.
  • Business Quant data shows Cash from Financing Activities for CCRN at -$6.5 million in Q4 2025, -$6000.0 in Q3 2025, and -$1.8 million in Q2 2025.